POLYACTIVA
PolyActiva has developed proprietary drug-polymer conjugate technology that enables site-specific drug delivery from medical device components such as ocular implants, intra-articular gel implants, and drug-eluting fibers.
POLYACTIVA
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2009-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.polyactiva.com
Total Employee:
11+
Status:
Active
Contact:
61 3 9657 0700
Email Addresses:
[email protected]
Total Funding:
12.96 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API WordPress Content Delivery Network Font Awesome Organization Schema Sitelinks Search Box
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Medical Research Future Fund (MRFF)
Medical Research Future Fund (MRFF) investment in Grant - PolyActiva
Brandon Capital
Brandon Capital investment in Grant - PolyActiva
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Series B - PolyActiva
Yuuwa Capital
Yuuwa Capital investment in Series B - PolyActiva
Brandon Capital
Brandon Capital investment in Series B - PolyActiva
State Government of Victoria
State Government of Victoria investment in Series A - PolyActiva
Official Site Inspections
http://www.polyactiva.com
- Host name: 45-79-237-164.ip.linodeusercontent.com
- IP address: 45.79.237.164
- Location: Fremont United States
- Latitude: 37.5625
- Longitude: -122.0004
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94536
More informations about "PolyActiva"
PolyActiva - Crunchbase Company Profile & Funding
Organization. PolyActiva . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... PolyActiva has developed proprietary drug-polymer conjugate technology that enables site …See details»
About - PolyActiva
Visionary Leadership PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and …See details»
PolyActiva Company Profile 2024: Valuation, Funding & Investors
PolyActiva General Information Description. Developer of drug-polymer conjugates designed for site-specific drug delivery from medical device components. The company offers a delivery …See details»
PolyActiva - Company Profile & Staff Directory - ContactOut
PolyActiva is an Australian-based biotechnology company that has developed a platform technology to deliver drugs to specific sites in the body. The polymeric prodrugs can take …See details»
PolyActiva Company Profile - Office Locations, Competitors ... - Craft
PolyActiva has 5 employees at their 1 location and $11.38 m in total funding,. See insights on PolyActiva including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
PolyActiva - Overview, News & Similar companies | ZoomInfo.com
Mar 3, 2022 PolyActiva contact info: Phone number: +61 396570777 Website: www.polyactiva.com What does PolyActiva do? PolyActiva is an innovative clinical-stage …See details»
PolyActiva - Org Chart, Teams, Culture & Jobs - The Org
PolyActiva is an Australian-based biotechnology company that has developed a platform technology to deliver drugs to specific sites in the body. The polymeric prodrugs can take …See details»
PolyActiva Pty Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
PolyActiva Pty Ltd, a clinical-stage Australian biopharmaceutical company focused on developing unique biodegradable ocular implants with sustained drug delivery for patients suffering from …See details»
PolyActiva | Melbourne Startups
PolyActiva. Develops ocular implants for sustained drug release. PolyActiva is a Melbourne-based biotech company that specializes in developing ocular therapeutic products. Their work …See details»
POLYACTIVA PTY LTD Company Profile - Dun & Bradstreet
Polyactiva pty ltd. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / australia / victoria / notting …See details»
PolyActiva - Melbourne Biomedical Precinct
PolyActiva’s platform technology is used to deliver drugs to specific sites in the body and is particularly well suited to areas in the body that have limited volumes, for example the eye. …See details»
Team - PolyActiva
He joined PolyActiva in 2010 and as the Head of Chemistry, Pipeline Innovation and IP he oversees the team responsible for the innovation, optimization, development and manufacture …See details»
PolyActiva - VentureRadar
PolyActiva’s platform technology is used to deliver drugs to specific sites in the body with control over the rate of drug delivery for up to 12-months. The technology involves formation of a …See details»
PolyActiva - Contacts, Employees, Board Members, Advisors
Organization. PolyActiva . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
PolyActiva - Products, Competitors, Financials, Employees, …
PolyActiva has developed proprietary manufacturing processes and PA5108 has been successfully transferred to FDA-approved CDMOs. Starting materials and intermediates are …See details»
PolyActiva - Funding, Financials, Valuation & Investors - Crunchbase
PolyActiva develops products that enable drug release from medical devices. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
PolyActiva - Brandon Capital
San Francisco. Brandon Capital LLC. 1 Letterman Ave, Suite C3-330. San Francisco, CA 94129. Phone +61 3 9657 0700. Email: [email protected]See details»
PolyActiva's PA5108 Implant Shows Promise | OBN
Dec 4, 2024 • PolyActiva aims to address the adherence challenge, as studies indicate that 40% to 90% of patients discontinue correct use of eye drops within a year. Transforming Glaucoma …See details»
PolyActiva’s PA5108 glaucoma implant shows promising results in ...
Dec 3, 2024 PolyActiva’s phase 2 clinical trial of its PA5108 glaucoma implant met efficacy and safety end points, demonstrating more than 20% reduction in IOP. The biodegradable implant …See details»